Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Urticaria
Clinical narrative: Rashes are Bumpy, Itchy and like Scars on their Eczema; Loss of smell; loss of taste few days later; Had weakness; had allergic reaction by severe itching; Hives; Had fever of 102.2 a day after; chills; Rashes are reddish with some fluids coming out of its pores; Rashes are Bumpy, Itchy and like Scars on their Eczema; Rashes all over Belly and Thighs; feeling very tire for two days; This spontaneous case was reported by a patient and describes the occurrence of RASH ERYTHEMATOUS (Rashes are reddish with some fluids coming out of its pores), RASH PRURITIC (Rashes are Bumpy, Itchy and like Scars on their Eczema), ECZEMA (Rashes are Bumpy, Itchy and like Scars on their Eczema), ANOSMIA (Loss of smell) and AGEUSIA (loss of taste few days later) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hives and Hay fever. Previously administered products included for Product used for unknown indication: Tetanus (High fever) in 1985. Past adverse reactions to the above products included Headache with Tetanus. Concurrent medical conditions included Asthma (Improvement by immunotherapy) since 1973, Drug allergy (Bronchial spasm) since 08-Jun-2019, Cardiac disorder (Improvement by medication) since 2019 and Asthma (Mild and Improvement by medication) since 2019. Concomitant products included MONTELUKAST for Allergy and Asthma, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma, ROSUVASTATIN for Cholesterol, CLOPIDOGREL for Heart disease, unspecified.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced RASH ERYTHEMATOUS (Rashes are reddish with some fluids coming out of its pores) and RASH PRURITIC (Rashes are Bumpy, Itchy and like Scars on their Eczema). 07-May-2021, the patient experienced RASH (Rashes all over Belly and Thighs). On an unknown date, the patient experienced ECZEMA (Rashes are Bumpy, Itchy and like Scars on their Eczema), ANOSMIA (Loss of smell), AGEUSIA (loss of taste few days later), ASTHENIA (Had weakness), PRURITUS (had allergic reaction by severe itching), URTICARIA (Hives), FATIGUE (feeling very tire for two days), PYREXIA (Had fever of 102.2 a day after) and CHILLS (chills). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency; CLOBETASOL (cutaneous) on 03-Jul-2021 for Adverse event, at a dose of UNK UNK, tid and FLUOCINONIDE (cutaneous) on 15-Jun-2021 at a dose of 0.05%,  bid. At the time of the report, RASH ERYTHEMATOUS (Rashes are reddish with some fluids coming out of its pores), RASH PRURITIC (Rashes are Bumpy, Itchy and like Scars on their Eczema), ECZEMA (Rashes are Bumpy, Itchy and like Scars on their Eczema), AGEUSIA (loss of taste few days later), ASTHENIA (Had weakness), PRURITUS (had allergic reaction by severe itching), URTICARIA (Hives), RASH (Rashes all over Belly and Thighs), PYREXIA (Had fever of 102.2 a day after) and CHILLS (chills) outcome was unknown and FATIGUE (feeling very tire for two days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Apr-2021, Body temperature: 101.2 (High) 101.2 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Topical antibiotic cream  is the other treatment medication reported by reporter   Most recent FOLLOW-UP information incorporated above includes: On 17-Jul-2021: follow up received and patient demographics, medical history, vaccine details, treatment medication  and additional events were added.